January 24, 2025
FDA to continue enforcement discretion on compounded tirzepatide
Important answers to your questions about the current state of FDA’s enforcement when it comes to compounded tirzepatide injections. read more →
Another reason to attend the Owner Summit
We’ve got another awesome keynote at the 2025 Owner Summit: “16 Ways to Improve Employee Engagement” with Allison Linney. read more →
A different approach to regulation
The Texas State Board of Pharmacy is taking a different approach to USP chapter implementation. read more →
If you missed our email earlier this week, here’s an update for you on the Outsourcing Facilities Association/Farmakeio lawsuit against FDA. read more →
Reason #2 to come to the APC Owner Summit
Our second keynote will help you plan your business strategy. read more →
ADA parrots drugmakers on GLP-1 copies
We call out the American Diabetes Association's 'alternative facts' about compounded GLP-1s read more →
A good time to sharpen your skills
It's time to get up to snuff when it comes to compounding best practices (and we can help). read more →
Lilly intervenes in OFA lawsuit against FDA
Lilly says the FDA isn’t allowed to decide when compounders can compound FDA-approved drugs. read more →
CONTACT US
E-mail: info@a4pc.org
Phone: (281) 933-8400
Fax: (281) 495-0602
Mailing: Alliance for Pharmacy Compounding
100 Daingerfield Road, Ste. 100
Alexandria, VA 22314
APC is committed to addressing any concerns or complaints within one business day. Please send them — and, of course, any compliments — to info@a4pc.org.
THE APC FAMILY